Published in
Elsevier, Journal of Hepatology, 2(75), p. 363-376, 2021
DOI: 10.1016/j.jhep.2021.03.028
Links
Tools
FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted
Journal article published in 2021 by
Adrián Vallejo,
Oihane Erice,
Rodrigo Entrialgo-Cadierno 
,
Iker Feliu,
Elizabeth Guruceaga,
Maria J. Perugorria,
Paula Olaizola,
Alexandra Muggli,
Irati Macaya,
Michael O’Dell,
Borja Ruiz-Fernandez de Cordoba,
Sergio Ortiz-Espinosa,
Aram F. Hezel,
Imanol Arozarena,
Fernando Lecanda
and other authors.
,
Iker Feliu,
Elizabeth Guruceaga,
Maria J. Perugorria,
Paula Olaizola,
Alexandra Muggli,
Irati Macaya,
Michael O’Dell,
Borja Ruiz-Fernandez de Cordoba,
Sergio Ortiz-Espinosa,
Aram F. Hezel,
Imanol Arozarena,
Fernando Lecanda
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 